kth.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Studies on the mechanisms of action of adalimumab, a humanized anti-TNF antibody, on synovial inflammation and bone destruction, with a special focus on RANKL/RANK/OPG system
KTH, School of Biotechnology (BIO).
2011 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Place, publisher, year, edition, pages
2011.
National Category
Engineering and Technology
Identifiers
URN: urn:nbn:se:kth:diva-72243OAI: oai:DiVA.org:kth-72243DiVA, id: diva2:487335
Uppsok
Technology
Supervisors
Examiners
Available from: 2012-01-31 Created: 2012-01-31 Last updated: 2022-06-24Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
School of Biotechnology (BIO)
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 59 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf